Utilizing Tumor Models to Overcome Immune Resistance Mechanisms & Support Checkpoint Inhibitor Therapeutic Assessments
Time: 1:45 pm
day: Conference Day One - Track 1 - Post Lunch
Details:
- Discussing the role of Treg in immune resistance mechanisms to checkpoint inhibitors and cell therapies
- Reiterating role of CCR4 in the recruitment and accumulation of Treg in the tumor microenvironment
- Spotlighting updates on this work over the last 12 months
